NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-181-1999-0-DE-10 A Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector DE EP 00939374.5 Expired
NCI E-181-1999-0-CH-09 A Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector CH EP 00939374.5 Expired
NCI E-181-1999-0-GB-12 A Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector GB EP 00939374.5 Expired
NCI E-086-2004-0-JP-15 Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them JP National Stage 2002-559023 Expired
NCI E-086-2004-0-NL-13 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME NL EP 01989170.4 Expired
NCI E-086-2004-0-CH-05 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME CH EP 01989170.4 Expired
NCI E-086-2004-0-GB-10 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME GB EP 01989170.4 Expired
NCI E-086-2004-0-EP-04 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME EP National Stage 01989170.4 Expired
NCI E-086-2004-0-SE-14 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME SE EP 01989170.4 Expired
NCI E-086-2004-0-ES-08 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME ES EP 01989170.4 Expired
NCI E-086-2004-0-FR-09 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME FR EP 01989170.4 Expired
NCI E-086-2004-0-DE-06 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME DE EP 01989170.4 Expired
NCI E-086-2004-0-IT-12 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME IT EP 01989170.4 Expired
NCI E-086-2004-0-IE-11 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME IE EP 01989170.4 Expired
NCI E-086-2004-0-DK-07 PHARMACEUTICAL COMPOSITIONS OF FENRETINIDE HAVING INCREASED BIOAVAILABILITY AND METHODS OF USING THE SAME DK EP 01989170.4 Expired
NCI E-086-2004-0-US-02 Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them US ORD 10/010,914 7169819 Expired PDF
NCI E-086-2004-0-PCT-03 Pharmaceutical Compositions Of Fenretinide Having Increased Bioavailability And Methods Of Using Them PCT PCT PCT/US2001/465548 Expired
NHLBI E-200-2000-0-PCT-02 Accelerated Magnetic Resonance Imaging PCT PCT PCT/US2001/046949 Expired
NHLBI E-200-2000-0-EP-03 Accelerated Magnetic Resonance Imaging EP National Stage 01996151.5 Abandoned
NIAID E-125-2001-0-PCT-01 Novel Spore Wall Proteins and Genes from Microsporidia PCT PCT PCT/US01/47182 Abandoned
NHLBI E-232-1994-0-US-03 CHIRAL SEPARATION OF ENANTIOMERS BY HIGH-SPEED COUNTERCURRENT CHROMATOGRAPHY US DIV 10/005,847 6503398 Abandoned PDF
NIAID E-017-2001-0-AU-07 Monoclonal Antibodies Specific for the E2 Glycoprotein of Hepatitis C Virus and Their Use in the Diagnosis, Treatment, and Prevention of Hepatitis C AU National Stage 2002243259 Abandoned
NCI E-081-1999-2-US-01 Redox-stable, Non-Phosphorylated Cyclic Peptide Inhibitors of SH2 Domain Binding to Target Protein, Conjugates Thereof, Compositions and Methods of Synthesis and Use US CIP 09/998,350 6951915 Expired PDF
NCI E-287-2000-0-PCT-02 Cell-Free Assembly of Lentiviral Capsids PCT PCT PCT/US01/46919 Abandoned
NIAID E-017-2001-0-PCT-02 Monoclonal Antibodies Specific for the E2 Glycoprotein of Hepatitis C Virus and Their Use in the Diagnosis, Treatment, and Prevention of
Hepatitis C 		PCT PCT PCT/US01/45221 Abandoned
NINDS E-206-2000-0-US-02 Method of Increasing Distribution of Therapeutic Agents US ORD 09/999,203 Abandoned
NIAID E-017-2001-0-JP-06 Monoclonal Antibodies Specific for the E2 Glycoprotein of Hepatitis C Virus and Their Use in the Diagnosis, Treatment, and Prevention of Hepatitis C JP National Stage 2002-556628 Abandoned
NIAID E-017-2001-0-EP-05 Monoclonal Antibodies Specific for the E2 Glycoprotein of Hepatitis C Virus and Their Use in the Diagnosis, Treatment, and Prevention of .. EP National Stage 01989143.1 Abandoned
NIAID E-017-2001-0-CA-04 Monoclonal Antibodies Specific for the E2 Glycoprotein of Hepatitis C Virus and Their Use in the Diagnosis, Treatment, and Prevention of Hepatitis C. CA National Stage 2429946 Abandoned
NCI E-268-1997-4-US-01 MUCOSAL CYTOTOXIC T LYMPHOCYTE RESPONSES US 60/334,498 Abandoned
NCI E-123-2001-0-US-01 Pox Viral Vectors for Expressing Human Agonist CTL Epitopes of Prostate-Specific Antigen, And Usea thereof . US 60/334,575 Abandoned
NCI E-124-2001-0-US-01 The Identification of A Modified (Agonist) T-Cell Epitope of The Human Prostate-Specific Antigen (PSA) That Can Enhance The... US 60/334,669 Abandoned
NIDDK E-026-2002-0-US-01 P2X7 Receptor Antagonists US 60/334,130 Abandoned
NIEHS E-265-1998-0-PCT-02 Identification of Compounds That Potentiate The Activity of Muscarinic Potassium Channels PCT PCT PCT/US01/44727 Expired
NIAID E-099-1999-1-BR-03 Use of Recombinant Parainfluenza Viruses (PIV's) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens BR National Stage PI0105530-5 Abandoned
NIAID E-280-2001-0-US-01 Recovery of Recombinant Human Parainfluenza Virus Type 1 (HPIV1) From cDNA and Use of Recombinant HPIV1 as Vaccines And Vectors to ... US 60/331,961 Abandoned
NCI E-079-1999-3-AU-05 METHODS,DEVICES, ARRAYS AND KITS FOR DETECTING AND ANALYZING BIOMOLECULES AU National Stage 2002243236 Expired
NCI E-139-1999-0-US-07 Anti-mesothelin antibodies having high binding affinity US ORD 09/979,539 7081518 Expired PDF
NCI E-143-1996-0-US-04 NOVEL LIPOSOME COMPLEXES FOR INCREASED SYSTEMIC DELIVERY US CON 09/991,028 6770291 Expired PDF
NICHD E-043-1999-0-NZ-05 Utergolobin In The Treatment Of IgA Mediated Autoimmune Disorders NZ National Stage 515588 Expired
NCI E-079-1999-3-PCT-01 METHODS AND ARRAYS FOR DETECTING BIOMOLECULES PCT PCT COMB PCT/US2001/044009 Expired
NCI E-079-1999-3-JP-02 Methods, Devices, Arrays and Kits for Detecting and Analyzing Biomolecules JP National Stage 2002-549932 Abandoned
NCI E-079-1999-3-EP-06 Methods, Devices, Arrays and Kits for Detecting and Analyzing Biomolecules EP National Stage 01989119.1 Expired
CC E-013-1999-0-US-03 Magnetic Resonance Tracking of Magnetically Labeled Cells US National Stage 09/979,464 Abandoned
NCI E-079-1999-3-CA-04 METHODS, DEVICES, ARRAYS AND KITS FOR DETECTING AND ANALYZING BIOMOLECULES CA National Stage 2428441 Abandoned
NCI E-024-2002-0-PCT-01 Methods and Compositions of Defensin-Antigen Fusion Proteins and Chemokine-Antigen Fusion Proteins as Vaccines for Tumors and Viral Infection PCT PCT PCT/US01/43830 Abandoned
NCI E-146-1999-0-PCT-02 Reduction of the Nonspecific Animal Toxicity of Immunotoxin by Mutat- ing the framework regions of the Fv to Lower the Isoelectic Point PCT PCT PCT/US01/43602 Expired
NCI E-158-2000-0-US-01 A Rev Tat Nef (Retinef) Chimeric Protein as a Component of an HIV-I Vaccine. US 60/332,433 Abandoned
NCI E-158-2002-0-US-01 A Method to Screen Drug Libraries to Identify Drugs that Specifically Interact With Identified Proteins US 60/332,443 Abandoned
NICHD E-113-1999-0-CA-06 Sol Fusin: Use of GP64-6HIS To Catalyze Membrane Fusion CA National Stage 2429138 Abandoned